IP Library Granted Patent US 7,507,257
Granted Patent B2
US 7,507,257 · App. 10/772,108 · Granted Mar 24, 2009

Injectable resorbable bone graft material, powder for forming same and methods relating thereto for treating bone defects

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,507,257
App. No.
10/772,108
Granted
Mar 24, 2009
Kind
B2
Abstract

An injectable resorbable bone graft material, and methods of using the same, provide increased compressive strength after injection in a bone defect. The bone graft material is made from calcium sulfate hemihydrate having a thick stubby rod-like crystalline structure and low water-carrying capacity.

Claims (36)

1. A method for treating bone defects comprising the steps of mixing a powder comprising between about 99.8 to 100 percent by weight calcium sulfate hemihydrate, the calcium sulfate hemihydrate consisting of thick, stubby, rod-like crystals having a low water carrying capacity, with a diluent to produce an injectable resorbable bone graft material in the form of a paste; and injecting the injectable resorbable bone graft material in the bone defect, the injectable resorbable bone graft material having a compressive strength in excess of 15 MPa within one hour after said injecting step.

2. The method of claim 1 , wherein said bone graft material has a compressive strength of approximately 45-49 MPa within one hour after said injecting step.

3. The method of claim 1 , wherein said bone graft material has a compressive strength exceeding approximately 50 MPa within one hour after said injecting step.

4. The method of claim 1 , wherein the diluent is water or a solution comprising an inorganic salt or a cationic surface active agent.

5. The method of claim 1 , wherein the calcium sulfate hemihydrate is formed by immersing calcium sulfate dihydrate in a solution of water and an inorganic salt to form a mixture, and heating the mixture to substantially its boiling point at atmospheric pressure such that the calcium sulfate dihydrate is converted to calcium sulfate hemihydrate.

6. The method of claim 1 , wherein the injectable resorbable bone graft material has a working time of at least 5 minutes following mixing.

7. The method of claim 1 , wherein the injectable resorbable bone graft material further comprises an accelerant.

8. The method of claim 7 , wherein the accelerant is selected from the group consisting of calcium sulfate dihydrate, calcium sulfate dihydrate coated with sucrose, potassium sulfate, and sodium sulfate.

9. The method of claim 1 , wherein the injectable resorbable bone graft material further comprises one or more additives selected from the group consisting of bone marrow aspirate, platelet concentrate, blood, antibiotics, chemotherapeutic agents, growth factors, and analgesics.

10. The method of claim 1 , wherein the diluent to powder weight ratio is 0.19:1 to 0.31:1.

11. A method for treating bone defects comprising the steps of mixing a powder comprising between about 99.8 to 100 percent by weight calcium sulfate hemihydrate, the calcium sulfate hemihydrate consisting of thick, stubby, rod-like crystals having a low water carrying capacity, with a diluent to produce an injectable resorbable bone graft material in the form of a paste; and injecting the injectable resorbable bone graft material in the bone defect, said injectable resorbable bone graft material having a compressive strength of at least 6 MPa within 20 minutes after said injecting step.

12. The method of claim 11 , wherein the diluent is water or a solution comprising an inorganic salt or a cationic surface active agent.

13. The method of claim 11 , wherein the calcium sulfate hemihydrate is formed by immersing calcium sulfate dihydrate in a solution of water and an inorganic salt to form a mixture, and heating the mixture to substantially its boiling point at atmospheric pressure such that the calcium sulfate dihydrate is converted to calcium sulfate hemihydrate.

14. The method of claim 11 , wherein the injectable resorbable bone graft material has a working time of at least 5 minutes following mixing.

15. The method of claim 11 , wherein the injectable resorbable bone graft material further comprises an accelerant.

16. The method of claim 15 , wherein the accelerant is selected from the group consisting of calcium sulfate dihydrate, calcium sulfate dihydrate coated with sucrose, potassium sulfate, and sodium sulfate.

17. The method of claim 11 , wherein the injectable resorbable bone graft material further comprises one or more additives selected from the group consisting of bone marrow aspirate, platelet concentrate, blood, antibiotics, chemotherapeutic agents, growth factors, and analgesics.

18. The method of claim 11 , wherein the diluent to powder weight ratio is 0.19:1 to 0.31:1.

19. A method for treating bone defects comprising the steps of mixing a powder comprising between about 99.8 to 100 percent by weight calcium sulfate hemihydrate, the calcium sulfate hemihydrate consisting of thick, stubby, rod-like crystals having a low water carrying capacity, with a diluent to produce an injectable resorbable bone graft material in the form of a paste; and injecting the injectable resorbable bone graft material in the bone defect, said injectable resorbable bone graft material having a compressive strength of at least 35 MPa within 24 hours after said injecting step.

20. The method of claim 19 , wherein said bone graft material has a compressive strength of approximately 56 MPa within 24 hours after said injecting step.

21. The method of claim 19 , wherein the diluent is water or a solution comprising an inorganic salt or a cationic surface active agent.

22. The method of claim 19 , wherein the calcium sulfate hemihydrate is formed by immersing calcium sulfate dihydrate in a solution of water and an inorganic salt to form a mixture, and heating the mixture to substantially its boiling point at atmospheric pressure such that the calcium sulfate dihydrate is converted to calcium sulfate hemihydrate.

23. The method of claim 19 , wherein the injectable resorbable bone graft material has a working time of at least 5 minutes following mixing.

24. The method of claim 19 , wherein the injectable resorbable bone graft material further comprises an accelerant.

25. The method of claim 24 , wherein the accelerant is selected from the group consisting of calcium sulfate dihydrate, calcium sulfate dihydrate coated with sucrose, potassium sulfate, and sodium sulfate.

26. The method of claim 19 , wherein the injectable resorbable bone graft material further comprises one or more additives selected from the group consisting of bone marrow aspirate, platelet concentrate, blood, antibiotics, chemotherapeutic agents, growth factors, and analgesics.

27. The method of claim 19 , wherein the diluent to powder weight ratio is 0.19:1 to 0.31:1.

28. A method for treating bone defects comprising the steps of mixing a powder comprising between about 99.8 to 100 percent by weight calcium sulfate hemihydrate, the calcium sulfate hemihydrate consisting of thick, stubby, rod-like crystals having a low water carrying capacity, with a diluent to produce an injectable resorbable bone graft material in the form of a paste, wherein when undergoing dry-testing, said bone graft material has a compressive strength of approximately 88 MPa within 24 hours after said mixing step.

29. The method of claim 28 , wherein said bone graft material has a compressive strength exceeding approximately 106 MPa within 24 hours after said mixing step.

30. The method of claim 28 , wherein the diluent is water or a solution comprising an inorganic salt or a cationic surface active agent.

31. The method of claim 28 , wherein the calcium sulfate hemihydrate is formed by immersing calcium sulfate dihydrate in a solution of water and an inorganic salt to form a mixture, and heating the mixture to substantially its boiling point at atmospheric pressure such that the calcium sulfate dihydrate is converted to calcium sulfate hemihydrate.

32. The method of claim 28 , wherein the injectable resorbable bone graft material has a working time of at least 5 minutes following mixing.

33. The method of claim 28 , wherein the injectable resorbable bone graft material further comprises an accelerant.

34. The method of claim 33 , wherein the accelerant is selected from the group consisting of calcium sulfate dihydrate, calcium sulfate dihydrate coated with sucrose, potassium sulfate, and sodium sulfate.

35. The method of claim 28 , wherein the injectable resorbable bone graft material further comprises one or more additives selected from the group consisting of bone marrow aspirate, platelet concentrate, blood, antibiotics, chemotherapeutic agents, growth factors, and analgesics.

36. The method of claim 28 , wherein the diluent to powder weight ratio is 0.19:1 to 0.31:1.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Nov 19, 2020
From: MIDCAP FUNDING IV TRUST
To: WRIGHT MEDICAL GROUP N.V.; WRIGHT MEDICAL GROUP, INC.; BIOMIMETIC THERAPEUTICS CANADA, INC.; BIOMIMETIC THERAPEUTICS, LLC; BIOMIMETIC THERAPEUTICS USA, INC.; INBONE TECHNOLOGIES, INC.; ORTHOHELIX SURGICAL DESIGNS, INC.; ORTHOPRO, L.L.C.; SOLANA SURGICAL, LLC; TORNIER US HOLDINGS, INC.; TORNIER, INC.; TROOPER HOLDINGS INC.; WHITE BOX ORTHOPEDICS, LLC; WRIGHT MEDICAL CAPITAL, INC.; WRIGHT MEDICAL TECHNOLOGY, INC.; WRIGHT MEDICAL GROUP INTELLECTUAL PROPERTY, INC.
Reel/Frame 054480/0001 →
SECURITY INTEREST Recorded Jan 5, 2017
From: WRIGHT MEDICAL TECHNOLOGY, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041257/0126 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2004
From: CARROLL, MICHAEL E.; MOSELEY, JON P.; COLE, JANTZEN A.; RICHELSOPH, KELLY
To: WRIGHT MEDICAL TECHNOLOGY, INC.
Reel/Frame 015520/0447 →